As the interaction of Gal-3 with integrins promotes cancer progression, and integrins are one of the ERK upstream effectors [25,31], we next investigated whether FOXD1 expression is regulated by the Gal-3/ITGβ1/ERK axis. The gene discussed is MAPK1; the disease is cancer.